S&P 500   3,337.71 (-0.41%)
DOW   27,445.28 (-0.50%)
QQQ   275.95 (-0.45%)
AAPL   113.87 (-0.95%)
MSFT   207.33 (-1.01%)
FB   258.52 (+0.66%)
GOOGL   1,455.75 (-0.20%)
AMZN   3,161.10 (-0.41%)
TSLA   425.36 (+0.99%)
NVDA   530.69 (+1.78%)
BABA   276.81 (+0.29%)
CGC   14.53 (+2.25%)
MU   50.68 (+1.93%)
GE   6.06 (-2.26%)
AMD   81.98 (+3.15%)
T   28.18 (-0.70%)
F   6.60 (-1.35%)
ACB   4.81 (+0.63%)
GILD   61.99 (-1.37%)
NFLX   493.72 (+0.63%)
DIS   123.94 (-1.63%)
BA   162.99 (-1.86%)
BAC   23.72 (-1.54%)
S&P 500   3,337.71 (-0.41%)
DOW   27,445.28 (-0.50%)
QQQ   275.95 (-0.45%)
AAPL   113.87 (-0.95%)
MSFT   207.33 (-1.01%)
FB   258.52 (+0.66%)
GOOGL   1,455.75 (-0.20%)
AMZN   3,161.10 (-0.41%)
TSLA   425.36 (+0.99%)
NVDA   530.69 (+1.78%)
BABA   276.81 (+0.29%)
CGC   14.53 (+2.25%)
MU   50.68 (+1.93%)
GE   6.06 (-2.26%)
AMD   81.98 (+3.15%)
T   28.18 (-0.70%)
F   6.60 (-1.35%)
ACB   4.81 (+0.63%)
GILD   61.99 (-1.37%)
NFLX   493.72 (+0.63%)
DIS   123.94 (-1.63%)
BA   162.99 (-1.86%)
BAC   23.72 (-1.54%)
S&P 500   3,337.71 (-0.41%)
DOW   27,445.28 (-0.50%)
QQQ   275.95 (-0.45%)
AAPL   113.87 (-0.95%)
MSFT   207.33 (-1.01%)
FB   258.52 (+0.66%)
GOOGL   1,455.75 (-0.20%)
AMZN   3,161.10 (-0.41%)
TSLA   425.36 (+0.99%)
NVDA   530.69 (+1.78%)
BABA   276.81 (+0.29%)
CGC   14.53 (+2.25%)
MU   50.68 (+1.93%)
GE   6.06 (-2.26%)
AMD   81.98 (+3.15%)
T   28.18 (-0.70%)
F   6.60 (-1.35%)
ACB   4.81 (+0.63%)
GILD   61.99 (-1.37%)
NFLX   493.72 (+0.63%)
DIS   123.94 (-1.63%)
BA   162.99 (-1.86%)
BAC   23.72 (-1.54%)
S&P 500   3,337.71 (-0.41%)
DOW   27,445.28 (-0.50%)
QQQ   275.95 (-0.45%)
AAPL   113.87 (-0.95%)
MSFT   207.33 (-1.01%)
FB   258.52 (+0.66%)
GOOGL   1,455.75 (-0.20%)
AMZN   3,161.10 (-0.41%)
TSLA   425.36 (+0.99%)
NVDA   530.69 (+1.78%)
BABA   276.81 (+0.29%)
CGC   14.53 (+2.25%)
MU   50.68 (+1.93%)
GE   6.06 (-2.26%)
AMD   81.98 (+3.15%)
T   28.18 (-0.70%)
F   6.60 (-1.35%)
ACB   4.81 (+0.63%)
GILD   61.99 (-1.37%)
NFLX   493.72 (+0.63%)
DIS   123.94 (-1.63%)
BA   162.99 (-1.86%)
BAC   23.72 (-1.54%)
Log in
NASDAQ:JNCE

Jounce Therapeutics News Headlines

$8.11
-0.05 (-0.61 %)
(As of 09/29/2020 01:12 PM ET)
Add
Compare
Today's Range
$7.99
Now: $8.11
$8.24
50-Day Range
$4.67
MA: $6.69
$10.95
52-Week Range
$2.79
Now: $8.11
$11.72
Volume14,553 shs
Average Volume645,389 shs
Market Capitalization$276.29 million
P/E Ratio13.08
Dividend YieldN/A
Beta2.11

Headlines

Jounce Therapeutics (NASDAQ JNCE) News Headlines Today

Source:
DateHeadline
Jounce Therapeutics (NASDAQ:JNCE) Coverage Initiated by Analysts at Roth CapitalJounce Therapeutics (NASDAQ:JNCE) Coverage Initiated by Analysts at Roth Capital
marketbeat.com - September 18 at 9:34 AM
Jounce Therapeutics (NASDAQ:JNCE) Trading Down 8.8%Jounce Therapeutics (NASDAQ:JNCE) Trading Down 8.8%
americanbankingnews.com - September 23 at 7:41 PM
Jounce Therapeutics (NASDAQ:JNCE) Receives New Coverage from Analysts at Roth CapitalJounce Therapeutics (NASDAQ:JNCE) Receives New Coverage from Analysts at Roth Capital
americanbankingnews.com - September 18 at 10:48 AM
Insider Selling: Jounce Therapeutics Inc (NASDAQ:JNCE) Director Sells 10,000 Shares of StockInsider Selling: Jounce Therapeutics Inc (NASDAQ:JNCE) Director Sells 10,000 Shares of Stock
americanbankingnews.com - September 17 at 12:12 AM
Jounce Therapeutics (NASDAQ:JNCE) Trading Down 14.1%Jounce Therapeutics (NASDAQ:JNCE) Trading Down 14.1%
americanbankingnews.com - September 16 at 8:35 PM
Stock Alert: Jounce Therapeutics Touches New HighStock Alert: Jounce Therapeutics Touches New High
nasdaq.com - September 15 at 12:52 PM
Jounce Therapeutics (NASDAQ:JNCE) Trading 6.8% Higher Jounce Therapeutics (NASDAQ:JNCE) Trading 6.8% Higher
americanbankingnews.com - September 14 at 8:44 PM
Heres What We Learned About The CEO Pay At Jounce Therapeutics, Inc. (NASDAQ:JNCE)Here's What We Learned About The CEO Pay At Jounce Therapeutics, Inc. (NASDAQ:JNCE)
finance.yahoo.com - September 11 at 11:54 PM
Jounce Therapeutics (NASDAQ:JNCE) Trading 12% Higher Jounce Therapeutics (NASDAQ:JNCE) Trading 12% Higher
americanbankingnews.com - September 8 at 6:30 PM
Jounce Therapeutics (NASDAQ:JNCE) Stock Price Down 7.3%Jounce Therapeutics (NASDAQ:JNCE) Stock Price Down 7.3%
americanbankingnews.com - September 4 at 8:05 PM
Jounce Therapeutics to Participate in Upcoming Virtual Investor Conferences in SeptemberJounce Therapeutics to Participate in Upcoming Virtual Investor Conferences in September
finance.yahoo.com - September 2 at 6:55 PM
Gilead Inks Deal With Jounce to License an Oncology CandidateGilead Inks Deal With Jounce to License an Oncology Candidate
finance.yahoo.com - September 2 at 1:55 PM
Why This Gilead Deal Is Huge For Jounce TherapeuticsWhy This Gilead Deal Is Huge For Jounce Therapeutics
msn.com - September 2 at 12:46 AM
P/E Ratio Insights for Jounce TherapeuticsP/E Ratio Insights for Jounce Therapeutics
finance.yahoo.com - September 1 at 2:44 PM
Jounce Therapeutics (JNCE) CEO Rich Murray on Q2 2020 Results - Earnings Call TranscriptJounce Therapeutics' (JNCE) CEO Rich Murray on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 1:53 PM
Jounce Therapeutics, Inc. (JNCE) Q2 2020 Earnings Call TranscriptJounce Therapeutics, Inc. (JNCE) Q2 2020 Earnings Call Transcript
nasdaq.com - August 7 at 1:53 PM
Jounce Therapeutics Reports Second Quarter 2020 Financial ResultsJounce Therapeutics Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 7 at 8:05 AM
Jounce Therapeutics to Participate in a Fireside Chat at BTIG Virtual Biotechnology Conference 2020Jounce Therapeutics to Participate in a Fireside Chat at BTIG Virtual Biotechnology Conference 2020
finance.yahoo.com - August 4 at 10:04 AM
Jounce Therapeutics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Friday, August 7, 2020Jounce Therapeutics to Announce Second Quarter 2020 Financial Results and Host Conference Call on Friday, August 7, 2020
finance.yahoo.com - July 31 at 8:56 AM
What Type Of Shareholders Make Up Jounce Therapeutics, Inc.s (NASDAQ:JNCE) Share Registry?What Type Of Shareholders Make Up Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) Share Registry?
finance.yahoo.com - July 28 at 5:48 PM
What Type Of Shareholders Make Up Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) Share Registry?What Type Of Shareholders Make Up Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) Share Registry?
finance.yahoo.com - July 28 at 12:47 PM
Should You Avoid Jounce Therapeutics, Inc. (JNCE)?Should You Avoid Jounce Therapeutics, Inc. (JNCE)?
finance.yahoo.com - July 6 at 12:30 AM
Jounce Therapeutics Presents First Preclinical Data on Anti-CCR8 Antibody JTX-1811 and Vopratelimab Translational Data at The American Association for Cancer Research Virtual Annual MeetingJounce Therapeutics Presents First Preclinical Data on Anti-CCR8 Antibody JTX-1811 and Vopratelimab Translational Data at The American Association for Cancer Research Virtual Annual Meeting
finance.yahoo.com - June 22 at 9:50 AM
Jounce Therapeutics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation ConferenceJounce Therapeutics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference
finance.yahoo.com - June 10 at 8:32 AM
Jounce Therapeutics Regains Worldwide Rights to JTX-8064 from Bristol Myers SquibbJounce Therapeutics Regains Worldwide Rights to JTX-8064 from Bristol Myers Squibb
finance.yahoo.com - June 4 at 9:27 AM
Jounce Therapeutics to Hold Virtual Meeting of StockholdersJounce Therapeutics to Hold Virtual Meeting of Stockholders
finance.yahoo.com - June 2 at 12:13 PM
Jounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q1 2020 Results - Earnings Call TranscriptJounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 4:18 PM
Earnings Update: Jounce Therapeutics, Inc. (NASDAQ:JNCE) Just Reported And Analysts Are Trimming Their ForecastsEarnings Update: Jounce Therapeutics, Inc. (NASDAQ:JNCE) Just Reported And Analysts Are Trimming Their Forecasts
finance.yahoo.com - May 9 at 4:18 PM
JNCE Jounce Therapeutics, Inc. Common StockJNCE Jounce Therapeutics, Inc. Common Stock
www.nasdaq.com - May 7 at 6:48 PM
Jounce Therapeutics, Inc. (JNCE) Q1 2020 Earnings Call TranscriptJounce Therapeutics, Inc. (JNCE) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 7 at 3:46 AM
Jounce Therapeutics EPS misses by $0.21Jounce Therapeutics EPS misses by $0.21
seekingalpha.com - May 6 at 1:00 PM
Jounce Therapeutics Reports First Quarter 2020 Financial ResultsJounce Therapeutics Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 6 at 1:00 PM
Recap: Jounce Therapeutics Q1 EarningsRecap: Jounce Therapeutics Q1 Earnings
finance.yahoo.com - May 6 at 1:00 PM
Jounce Therapeutics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020Jounce Therapeutics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020
finance.yahoo.com - April 29 at 5:11 PM
Jounce Therapeutics, Inc.s (NASDAQ:JNCE) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
finance.yahoo.com - April 21 at 11:41 AM
Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
finance.yahoo.com - April 21 at 11:41 AM
Jounce Therapeutics, Inc. (JNCE) Q4 2019 Earnings Call TranscriptJounce Therapeutics, Inc. (JNCE) Q4 2019 Earnings Call Transcript
www.fool.com - February 27 at 11:41 PM
Jounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q4 2019 Results - Earnings Call TranscriptJounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 1:40 PM
Jounce Therapeutics, Inc. to Host Earnings CallJounce Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - February 27 at 8:39 AM
Jounce Therapeutics Reports Fourth Quarter and Full Year 2019 Financial ResultsJounce Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - February 27 at 8:39 AM
Jounce Therapeutics to Present at Upcoming Investor Conferences in MarchJounce Therapeutics to Present at Upcoming Investor Conferences in March
finance.yahoo.com - February 26 at 8:29 AM
Jounce Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020Jounce Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, February 27, 2020
finance.yahoo.com - February 21 at 2:38 PM
Is Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) CEO Salary Justified?Is Jounce Therapeutics, Inc.'s (NASDAQ:JNCE) CEO Salary Justified?
finance.yahoo.com - February 21 at 9:37 AM
Whats in Store for Jounce (JNCE) This Earnings Season?What's in Store for Jounce (JNCE) This Earnings Season?
www.nasdaq.com - February 20 at 12:56 PM
What's in Store for Jounce (JNCE) This Earnings Season?What's in Store for Jounce (JNCE) This Earnings Season?
finance.yahoo.com - February 20 at 12:56 PM
Jounce Therapeutics: An Attractive Immunotherapy Pick For 2020Jounce Therapeutics: An Attractive Immunotherapy Pick For 2020
seekingalpha.com - February 20 at 7:56 AM
Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString TechnologiesJounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString Technologies
finance.yahoo.com - February 6 at 8:27 AM
Jounce Therapeutics - Will It EMERGE Stronger? Jounce Therapeutics - Will It EMERGE Stronger?
www.rttnews.com - February 4 at 5:15 AM
Jounce Therapeutics, Inc.Jounce Therapeutics, Inc.
www.fool.com - January 30 at 11:44 PM
Jounce Should Be On Your Radar With Differentiated Approach To Activating Immune SystemJounce Should Be On Your Radar With Differentiated Approach To Activating Immune System
seekingalpha.com - January 30 at 6:43 PM
Jounce Therapeutics Appoints Robert Iannone, M.D., M.S.C.E., to its Board of DirectorsJounce Therapeutics Appoints Robert Iannone, M.D., M.S.C.E., to its Board of Directors
finance.yahoo.com - January 23 at 5:30 PM
This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.